Genetic Variant on PDGFRL Associated with Behçet Disease in Chinese Han Populations

Human Mutation

Volumn 34, Issue 1, 2013, Pages 74-78

  Hou, Shengping ^a   Xiao, Xiang ^a   Zhou, Yan ^a   Zhu, Xiao ^b   Li, Fuzhen ^a   Kijlstra, Aize ^c   Yang, Peizeng ^a  

^a THE FIRST AFFILIATED HOSPITAL OF CHONGQING MEDICAL UNIVERSITY   (China)

^b MEDICAL COLLEGE OF GEORGIA   (United States)

^c MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Association; Beh et disease; Expression; PDGFRL; Polymorphism

Indexed keywords

ALLELE; ARTICLE; BEHCET DISEASE; CHINESE; CONTROLLED STUDY; GENE; GENE LOCUS; GENE REPLICATION; GENETIC VARIABILITY; GENOTYPE; HAPLOTYPE; HUMAN; MAJOR CLINICAL STUDY; PLATELET DERIVED GROWTH FACTOR RECEPTOR LIGAND GENE; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM;

ADULT; ALLELES; ASIAN CONTINENTAL ANCESTRY GROUP; BEHCET SYNDROME; CHINA; FEMALE; GENE EXPRESSION; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; LINKAGE DISEQUILIBRIUM; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTORS, PLATELET-DERIVED GROWTH FACTOR; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TUMOR SUPPRESSOR PROTEINS;

EID: 84871620678     PISSN: 10597794     EISSN: 10981004     Source Type: Journal    
DOI: 10.1002/humu.22208     Document Type: Article

References (25)

1. Baroni SS, Santillo M, Bevilacqua F, Luchetti M, Spadoni T, Mancini M, Fraticelli P, Sambo P, Funaro A, Kazlauskas A, Avvedimento EV, Gabrielli A. 2006. Stimulatory autoantibodies to the PDGF receptor in systemic sclerosis. N Engl J Med 354:2667-2676.
2. de Menthon M, Lavalley MP, Maldini C, Guillevin L, Mahr A. 2009. HLA-B51/B5 and the risk of Behcet's disease: a systematic review and meta-analysis of case-control genetic association studies. Arthritis Rheum 61:1287-1296.
3. Fujikado N, Saijo S, Iwakura Y. 2006. Identification of arthritis-related gene clusters by microarray analysis of two independent mouse models for rheumatoid arthritis. Arthritis Res Ther 8:R100.
4. Gul A, Hajeer AH, Worthington J, Barrett JH, Ollier WE, Silman AJ. 2001. Evidence for linkage of the HLA-B locus in Behcet's disease, obtained using the transmission disequilibrium test. Arthritis Rheum 44:239-240.
5. Gul A, Inanc M, Ocal L, Aral O, Konice M. 2000. Familial aggregation of Behcet's disease in Turkey. Ann Rheum Dis 59:622-625.
6. Hou S, Yang P, Du L, Zhou H, Lin X, Liu X, Kijlstra A. 2008. SUMO4 gene polymorphisms in Chinese Han patients with Behcet's disease. Clin Immunol 129:170-175.
7. International Study Group for Behcet's Disease. 1990. Criteria for diagnosis of Behcet's disease. Lancet 335:1078-1080.
8. Jiang Z, Yang P, Hou S, Du L, Xie L, Zhou H, Kijlstra A. 2010. IL-23R gene confers susceptibility to Behcet's disease in a Chinese Han population. Ann Rheum Dis 69:1325-1328.
9. Kahng YS, Lee YS, Kim BK, Park WS, Lee JY, Kang CS. 2003. Loss of heterozygosity of chromosome 8p and 11p in the dysplastic nodule and hepatocellular carcinoma. J Gastroenterol Hepatol 18:430-436.
10. Kone-Paut I, Geisler I, Wechsler B, Ozen S, Ozdogan H, Rozenbaum M, Touitou I. 1999. Familial aggregation in Behcet's disease: high frequency in siblings and parents of pediatric probands. J Pediatr 135:89-93.
11. Krause L, Kohler AK, Altenburg A, Papoutsis N, Zouboulis CC, Pleyer U, Stroux A, Foerster MH. 2009. Ocular involvement is associated with HLA-B51 in Adamantiades-Behcet's disease. Eye (Lond) 23:1182-1186.
12. Kunz M, Ibrahim SM. 2009. Cytokines and cytokine profiles in human autoimmune diseases and animal models of autoimmunity. Mediators Inflamm 2009:979258.
13. Lerebours F, Olschwang S, Thuille B, Schmitz A, Fouchet P, Buecher B, Martinet N, Galateau F, Thomas G. 1999. Fine deletion mapping of chromosome 8p in non-small-cell lung carcinoma. Int J Cancer 81:854-858.
14. Louvet C, Szot GL, Lang J, Lee MR, Martinier N, Bollag G, Zhu S, Weiss A, Bluestone JA. 2008. Tyrosine kinase inhibitors reverse type 1 diabetes in nonobese diabetic mice. Proc Natl Acad Sci USA 105:18895-18900.
15. Mizuki N, Meguro A, Ota M, Ohno S, Shiota T, Kawagoe T, Ito N, Kera J, Okada E, Yatsu K, Song YW, Lee EB, et al. 2010. Genome-wide association studies identify IL23R-IL12RB2 and IL10 as Behcet's disease susceptibility loci. Nat Genet 42:703-706.
16. Mizuki N, Ota M, Yabuki K, Katsuyama Y, Ando H, Palimeris GD, Kaklamani E, Accorinti M, Pivetti-Pezzi P, Ohno S, Inoko H. 2000. Localization of the pathogenic gene of Behcet's disease by microsatellite analysis of three different populations. Invest Ophthalmol Vis Sci 41:3702-3708.
17. Paniagua RT, Sharpe O, Ho PP, Chan SM, Chang A, Higgins JP, Tomooka BH, Thomas FM, Song JJ, Goodman SB, Lee DM, Genovese MC, et al. 2006. Selective tyrosine kinase inhibition by imatinib mesylate for the treatment of autoimmune arthritis. J Clin Invest 116:2633-2642.
18. Redlich K, Kiener HP, Schett G, Tohidast-Akrad M, Selzer E, Radda I, Stummvoll GH, Steiner CW, Groger M, Bitzan P, Zenz P, Smolen JS, et al. 2001. Overexpression of transcription factor Ets-1 in rheumatoid arthritis synovial membrane: regulation of expression and activation by interleukin-1 and tumor necrosis factor alpha. Arthritis Rheum 44:266-274.
19. Remmers EF, Cosan F, Kirino Y, Ombrello MJ, Abaci N, Satorius C, Le JM, Yang B, Korman BD, Cakiris A, Aglar O, Emrence Z and others. 2010. Genome-wide association study identifies variants in the MHC class I, IL10, and IL23R-IL12RB2 regions associated with Behcet's disease. Nat Genet 42:698-702.
20. Russell L, Garrett-Sinha LA. 2010. Transcription factor Ets-1 in cytokine and chemokine gene regulation. Cytokine 51:217-226.
21. Tan FK, Hildebrand BA, Lester MS, Stivers DN, Pounds S, Zhou X, Wallis DD, Milewicz DM, Reveille JD, Mayes MD, Jin L, Arnett Jr. FC. 2005. Classification analysis of the transcriptosome of nonlesional cultured dermal fibroblasts from systemic sclerosis patients with early disease. Arthritis Rheum 52:865-876.
22. Tinazzi E, Dolcino M, Puccetti A, Rigo A, Beri R, Valenti MT, Corrocher R, Lunardi C. 2010. Gene expression profiling in circulating endothelial cells from systemic sclerosis patients shows an altered control of apoptosis and angiogenesis that is modified by iloprost infusion. Arthritis Res Ther 12:R131.
23. Wallace GR, Niemczyk E. 2011. Genetics in ocular inflammation-basic principles. Ocul Immunol Inflamm 19:10-18.
24. Wang D, John SA, Clements JL, Percy DH, Barton KP, Garrett-Sinha LA. 2005. Ets-1 deficiency leads to altered B cell differentiation, hyperresponsiveness to TLR9 and autoimmune disease. Int Immunol 17:1179-1191.
25. Xu M, Kao MC, Nunez-Iglesias J, Nevins JR, West M, Zhou XJ. 2008. An integrative approach to characterize disease-specific pathways and their coordination: a case study in cancer. BMC Genomics 9(Suppl 1):S12.